Search
Advanced search

Company search

Company/VAT no/Free text Country/City/Municipality

TURNOVER (x1000 DKK)

NET PROFIT (x1000 DKK)

EMPLOYEES

Share

Pierre Fabre Pharma Norden AB

Closing information (x1000 DKK)

Closing information 2024/12 2023/12 2022/12
Turnover 156,241 Less Arrow 139,769 More Arrow 162,323
Financial expenses 106 More Arrow 232 More Arrow 388
Earnings before taxes 5,568 Less Arrow 4,271 More Arrow 5,383
EBITDA 5,056 Less Arrow 4,082 More Arrow 5,919
Total assets 121,417 Less Arrow 105,296 Less Arrow 87,079
Current assets 120,862 Less Arrow 104,687 Less Arrow 86,459
Current liabilities 101,256 Less Arrow 89,050 Less Arrow 70,200
Equity capital 20,161 Less Arrow 16,246 More Arrow 16,879
- share capital 260 More Arrow 269 Less Arrow 267
Employees (average) 13 More Arrow 16 Less Arrow 15

Financial ratios

Fiscal year 2024/12 2023/12 2022/12
Solvency 16.6% Less Arrow 15.4% More Arrow 19.4%
Turnover per employee 12,019 Less Arrow 8,736 More Arrow 10,822
Profit as a percentage of turnover 3.6% Less Arrow 3.1% More Arrow 3.3%
Return on assets (ROA) 4.7% Less Arrow 4.3% More Arrow 6.6%
Current ratio 119.4% Less Arrow 117.6% More Arrow 123.2%
Return on equity (ROE) 27.6% Less Arrow 26.3% More Arrow 31.9%
Change turnover 21,095 Less Arrow -23,389 More Arrow 23,459
Change turnover % 16% Less Arrow -14% More Arrow 17%
Chg. No. of employees -3 More Arrow 1 Equal arrow 1
Chg. No. of employees % -19% More Arrow 7% Equal arrow 7%

Total value of public sale

Fiscal year 2024/12 2023/12 2022/12
Total value of public sale 0 Equal arrow 0 Equal arrow 0

Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank

The closing information is gathered directly from the companies or from Creditsafe.